Activity Summary:
Pulmonary arterial hypertension (PAH) management increasingly incorporates structured risk assessment to inform treatment decisions, yet many patients continue to remain above low-risk status despite available therapies. Clinicians must determine when risk assessment findings warrant a change in treatment, how to integrate hemodynamic and clinical data into decision-making, and how to balance disease control with treatment burden and patient preferences.

Across this podcast series, Dr. Vallerie McLaughlin shares practical, case-based insights on translating risk assessment into actionable treatment decisions. Through expert discussion and real-world clinical scenarios, the episodes examine when to escalate therapy, when continued observation may be appropriate, and when treatment simplification or de-escalation may be considered for carefully selected patients. The series also highlights shared decision-making, aligning treatment intensity with clinical need, and applying evidence-based strategies to support individualized care and improved outcomes for patients with PAH.

Activity Summary:
Pulmonary arterial hypertension (PAH) management increasingly relies on structured risk assessment to guide treatment decisions, yet many patients remain above low-risk status despite available therapies. Clinicians are often challenged with determining when risk assessment findings should prompt treatment modification, how to integrate hemodynamic and clinical data into decision-making, and how to balance disease control with treatment burden and patient preferences.

During this mini-module series, Dr. Vallerie McLauglin explores practical approaches to translating risk assessment into action. Through expert-led insights and real-world clinical cases, participants examine when to escalate therapy, when continued observation may be appropriate, and when treatment simplification or de-escalation may be considered in carefully selected patients. Particular emphasis is placed on shared decision-making, aligning treatment intensity with clinical need, and applying evidence-based strategies that support individualized care and improved outcomes for patients with PAH.

Activity Summary:
Build a practical foundation for recognizing and managing NF1-PN. These evidence-based mini-modules explores the biology and clinical presentation of NF1-PN, with a focus on early recognition, clinical decision-making, and appropriate next steps in care.

Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, From Recognition to Lifelong Management in NF1-PN

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Reference and Resource
Access to featured studies, abstracts, and other kit materials cited in the program.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Build a practical foundation for recognizing and managing NF1-PN. These evidence-based mini-modules explores the biology and clinical presentation of NF1-PN, with a focus on early recognition, clinical decision-making, and appropriate next steps in care.

Explore the fundamentals of recognizing and managing NF1-PN through these engaging, evidence-based podcasts. Hear expert insights on disease biology, clinical presentation, early recognition, and decision-making, including the rationale for MEK pathway targeting and key features that may warrant further evaluation or referral.

Designed for front-line clinicians, these podcasts provide practical perspectives to build confidence in recognizing NF1-PN, understanding emerging treatment approaches, and navigating early management decisions in a rapidly evolving therapeutic landscape.

Activity Summary:
To further expand knowledge from Optimizing the PAH Journey: Sequencing, Titration, and Therapy Transitions, presented by Dr. Namita Sood, HCPs can access a downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Reference and Resource Links
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Build a practical foundation for recognizing and managing NF1-PN. These evidence-based mini-modules explores the biology and clinical presentation of NF1-PN, with a focus on early recognition, clinical decision-making, and appropriate next steps in care.

Through clinical case scenarios and practical learning activities, participants will strengthen their understanding of NF1-PN pathophysiology, the rationale for MEK pathway targeting, and the clinical features that should prompt further evaluation or referral.

Designed for front-line clinicians, these foundational modules provide the knowledge and confidence to recognize NF1-PN, understand emerging treatment approaches, and navigate early management decisions in a rapidly evolving therapeutic landscape.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, Conversations in HIV: Patient Voices Guiding Physician Choices.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
The evolving PAH treatment landscape requires clinicians to make increasingly complex decisions throughout the course of patient care. From determining the most appropriate therapy and route of administration to adjusting treatment and navigating transitions, effective long-term management requires consideration of clinical response, tolerability, patient preferences, and treatment burden.

In this expert-led podcast, Dr. Namita Sood explores the practical realities of longitudinal PAH management through case-based discussion and clinical insights. Listeners will gain practical strategies for optimizing therapy through appropriate sequencing, titration, escalation, and de-escalation decisions, with a focus on navigating real-world challenges and supporting sustained treatment success for patients with PAH.

Activity Summary:
In this expert-led podcast, faculty explore the complexities of HIV care through real-world patient cases, examining the clinical, social, and individual factors that influence access to, uptake of, and persistence with antiretroviral therapy (ART).

The discussion addresses health equity and social determinants of health, long-term ART management across diverse populations, adherence and resistance considerations, and factors that may influence regimen selection and switching. Faculty also discuss strategies for preventing and managing metabolic and other comorbidities in people with HIV (PWH).

Listen in for practical, case-based insights that support individualized, patient-centered approaches to equitable and sustainable HIV care.

Activity Summary:
As the treatment landscape for pulmonary arterial hypertension (PAH) continues to evolve, clinicians face increasingly complex decisions regarding therapy sequencing, route selection, titration, and treatment transitions. Long-term success depends not only on selecting an appropriate therapy, but also on managing treatment over time while balancing efficacy, tolerability, patient preferences, and treatment burden.

Through a series of focused, case-based mini-modules, this educational activity explores the practical realities of longitudinal PAH management. Participants will gain expert insights into strategies for optimizing therapy through appropriate sequencing, titration, escalation, and de-escalation decisions.

Activity Summary:
This expert-led roundtable explores HIV care through the lens of real patient cases, examining the perspectives, concerns, and experiences that influence access to, uptake of, and persistence with antiretroviral therapy (ART). Through diverse case scenarios, experts discuss the complex factors that shape treatment decisions and long-term HIV care.

In-depth discussion focuses on health equity and social determinants of health affecting care, approaches to long-term ART management for diverse populations, and adherence and resistance considerations that may influence regimen selection and switching. The group also explores strategies for preventing and managing metabolic and other comorbidities in people with HIV (PWH), with an emphasis on individualized, patient-centered care.

Join us to engage in meaningful case-based dialogue and translate clinical insights into practical approaches that support equitable, sustainable, and comprehensive HIV care.

Activity Summary:
To further expand knowledge from From Diagnosis to Discontinuation: Rethinking the IPF Patient Experience, presented by Dr. Kevin R. Flaherty, HCPs can access a downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.